Lexeo Therapeutics
We are a clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Our leading drug product candidates target cardiovascular disease and Alzheimer’s disease. (Incorporated in Delaware) We were founded through a collaboration between the world-class gene therapy research at Weill Cornell Medicine and […]
September 29, 2023 Read More